MTP - Midatech Pharma receives noncompliance notice from Nasdaq

Midatech Pharma (NASDAQ:MTP) received a letter from the Listings Qualifications Department of the Nasdaq that it is not in compliance with the minimum bid price. The notification does not lead to immediate delisting of shares. It has a compliance period of 180 calendar days, or until Oct.10, 2022 to regain compliance. In the event MTP does not regain compliance by Oct. 10, the company may be eligible for an additional 180-day grace period to regain compliance. Post the second grace period, if MTP does not regain compliance then NASDAQ might delist its Depositary Shares from The NASDAQ Capital Market. The company's business operations are not affected by the receipt of the Notification Letter.

For further details see:

Midatech Pharma receives noncompliance notice from Nasdaq